Current paradigms and novel strategies in paediatric
Transcription
Current paradigms and novel strategies in paediatric
ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN European Society for Paediatric Gastroenterology, Hepatology and Nutrition Conference fees 16.30h-18.30h AB0 incompatible donors Khalid Sharif, Birmingham, UK Patrick Gerner, Essen, Germany Withdrawal of immune suppression after liver transplantation: current understanding of tolerance and clinical trials – facts and round table discussion and working group: requirements for joint approach Immunosuppression Sandy Feng, San Francisco, USA George Mazariegos, Pittsburgh, USA Including registration for conference, accommondation and meals 200,- € allied health professional (with supporting letter) 300,- € trainees (with supporting letter) 400,- € early bird 500,- € any late bookings, from 15.08.2013 summary of the day Ulrich Baumann, MD Hannover Medical School Paediatric Gastroenterology and Hepatology Carl Neuberg Str 1, 30625 Hannover, Germany Baumann.U@mh-hannover.de 20.00h Dinner Saturday, 14th Sep 2013 Donor organ shortage and novel indications 7.30h Breakfast 8.30h-11.00h How to improve organ allocation – learning from our neighbours: National experiences with cadaveric and live-related organ donation John Bucuvalas, Cincinnati, USA Ozlem Durmaz, Istanbul, Turkey Esteban Frauca, Madrid, Spain Antal Dezsofi, Budapest, Hungary Björn Fischler, Stockholm, Sweden 11.00h-11.30h Coffee break 11.30h-13.00h Challenging indications for liver transplantation: Urea cycle defects Patrick McKiernan, Birmingham, UK Mitochondrial disorders Nedim Hadzic, London, UK Malignancies Barbara Wildhaber, Geneva, Switzerland Maple syrup urinary disease George Mazariegos, Pittsburgh, USA Registration and further Information www.espghan.org Contact Information Courtyard Hannover Maschsee Arthur-Menge-Ufer 3, 30169 Hannover, Germany www.marriott.de/hotels/travel/hajcy-courtyard-hannover-maschsee Supported by the following organisations: 10.000€ Supported by Astellas Pharma GmbH with a sponsoring of 15.000€ 10.000€ summary of the day 13.00h Farewell and Lunch 10.000€ Current paradigms and novel strategies in paediatric liver transplantation 12th − 14th September 2013 Place of Conference 2000€ Monothematic conference ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN ESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHANESPGHAN Dear colleagues It is with great pleasure that we invite you to the first ESPGHAN monothematic conference on paediatric liver transplantation! Thursday, 12th Sep 2013 Friday, 13th Sep 2013 Improving late outcome of liver tx Immunology From 11.30h 7.30h Coffee 8.00h Overview: Transplant immunology and tolerance Christine Falk, Hannover, Germany 8.30h-9.00h PTLD and malignancy Stefan Gottschalk, Houston, USA Britta Maecker-Kolhoff, Hannover, Germany From 12.00h Lunch Over the last 25 years paediatric liver transplantation has emerged from an experimental concept to established medical therapy. This successful development forces us to continuously consider new approaches to further improve the care of liver transplanted children. This monothematic conference on paediatric liver transplantation is organized on behalf of the ESPGHAN Hepatology Committee. The focus will be on improving late outcomes and organ allocation strategies, transplant immunology, and new and challenging indications. Single centre experiences, pro- and con debates, as well as deeper reviews will be presented, with the primary objective to encourage constructive discussions. We aim to provide both, a statement of current expertise and discussions on future prospects in our field! We look forward to welcoming you to Hannover! for the ESPGHAN hepatology committee: Ulrich Baumann Hannover Piotr Socha, Warsaw Antal Dezsofi, Budapest Ozlem Durmaz, Istanbul Nedim Hadzic, London Loreto Hierro, Madrid Valerio Nobili, Rome Pietro Vajro, Salerno Björn Fischler Stockholm Valerie McLin Geneva 13.45h Welcome 14.00h-14.20h Overview of long term outcome: Survival and ELTR data Vincent Karam, Paris, France 14.20h-16.30h Centre experience, multiple presentations: Long term QoL, cognitive and neurodevel opmental outcome Dominique Debray, Paris, France Vicky Ng, Toronto, Canada Infection and sepsis NN Cardiovascular complications Valerie McLin, Geneva, Switzerland Annette Melk, Hannover, Germany Renal comorbidity and need for kidney transplantation NN 16.30h-17.00h Coffee break 17.00h-18.30h Centre presentations, cont. Portal hypertension after liver transplantation: causes and approach Lorenzo d'Antiga, Bergamo, Italy Jean de Ville de Goyet, Rome, Italy Cholangiopathies after liver transplantation: causes and approach Michele Colledan, Bergamo, Italy Stephanie Franchi, Paris, France Nikolas Richter, Hannover, Germany summary of the day 20.00h Dinner Breakfast 9.00h-11.00h Steroid-free immunosuppression: Clinical trials and case series Raymond Reding, Brussels, Belgium Marco Sciveres, Palermo, Italy Ulrich Baumann, Hannover, Germany Experience with Calcineurin-inhibitor sparing regimen Patrick McKiernan, Birmingham, UK Funda Ozgenç, Izmir, Turkey mTOR inhibitor based immunosuppression: Paediatric and adult experience Anil Dhawan, London, UK Rainer Ganschow, Hamburg, Germany Christian Toso, Geneva, Switzerland 11.00h-11.30h Coffee break 11.30h-12.30 Role of donor specific antibodies in liver transplantation Loreto Hierro, Madrid, Spain Dendritic cell therapy and other strategies to induce tolerance Marie Cristina Cuturi, Nantes, France 12.30h-14.00h Lunch 14.00h-16.00h de novo – autoimmune hepatitis vs. rejection in liver biopsies post liver transplantation Stefan Hübscher, Birmingham, UK Protocol biopsies in paediatric liver transplantation Deirdre Kelly, Birmingham, UK Simon Horslen, Seattle, USA 16.00h-16.30h Coffee break